Posts

Showing posts with the label Infectious Diseases

Mosquito controls with AGO bucket traps, Autocidal Gravid Ovitrap (AGO), tested by CDC

Autocidal Gravid Ovitrap (AGO) bucket trap is a standard 5-gallon bucket adapted in a specific way to capture mosquitoes. AGO traps are available for purchase online from Springstar. Two traps cost $75, free shipping: https://www.springstar.net/collections/mosquitoes/products/ago The Autocidal Gravid Ovitrap (AGO trap), was developed by the Center for Disease Control (CDC) and has been proven to reduce populations of Aedes mosquitoes by over 80%. It is effective for the mosquitoes that transmit Zika, dengue, chikungunya, and yellow fever. No pesticides or pheromones required. Just add water and a little hay. From Springstar website: "The Trap-N-Kill® Autocidal Gravid Ovitrap is an 18 liter black bucket fitted with a “capture chamber” on the top. The capture chamber allows you to swap out the sticky board without having to pull off the whole lid. Twist the top half of the chamber and you'll have access to where the sticky board rests. The bucket itself is filled with water up ...

Even short term use of oral steroids (less than 30 days) linked to increased risk of severe infection (sepsis), blood clots and fracture

One in five American adults in a commercially insured plan were given prescriptions for short term use of oral corticosteroids during a three year period, with an associated increased risk of adverse events. Of 1.5 million adults, 21% received at least 1 prescription for oral corticosteroids over 3 period. The most common indications for use were: - upper respiratory tract infections - spinal conditions - allergies. Within 30 days of drug initiation, there was an increase in rates of: - sepsis - venous thromboembolism - fracture Risk over the subsequent 31–90 days. The increased risk persisted at prednisone equivalent doses of less than 20 mg/day. References: Short Term Use of Oral Corticosteroids and Related Harms http://buff.ly/2pI5qDY

Easier schedule for HPV vaccine: 2 doses instead of previously recommended 3

Image
From Mayo Clinic: To protect against cervical cancer and other cancers caused by HPV infection, the Centers for Disease Control (CDC) is now recommending that 11- and 12-year-olds receive two doses of HPV vaccine at least six months apart. This is a change from the previously recommended three-dose series. The CDC says adolescents ages 13–14 also can receive the HPV vaccine on the new two-dose schedule. However, those who start the series later will continue to need three doses. Self-administered HPV Test is one of the Top 10 Medical Innovations 2017, selected by the Cleveland Clinic: